Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-19

Clinical Trial Update: Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating whether ursodeoxycholic acid can mitigate statin-induced impaired glucose tolerance in patients with hyperlipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Hyperlipidemia, Ursodeoxycholic Acid | NA | Status: RECRUITING